reglab/housing_qa huggingface dataset:
22 ME Rev Stat § 8715 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 6: FACILITIES FOR CHILDREN AND ADULTS|Chapter 1683: MAINE HEALTH DATA ORGANIZATION|Subchapter 1: GENERAL PROVISIONS|22 §8715. Public health (WHOLE SECTION TEXT EFFECTIVE ON CONTINGENCY: See PL 2013, c. 528, §12)

 §8715. Public health (CONTAINS TEXT WITH VARYING EFFECTIVE DATES)(WHOLE SECTION TEXT EFFECTIVE ON CONTINGENCY: See PL 2013, c. 528, §12)1.  Permitted use and disclosure to public health authorities.  The organization may disclose protected health information, without an individual's authorization, to a public health authority for public health purposes mandated by state or federal law.   [PL 2013, c. 528, §10 (NEW); PL 2013, c. 528, §12 (AFF).] 2.  Use by public health authority.  A state or federal public health authority to which protected health information has been disclosed under subsection 1 may use that information for public health activities and may disclose that information for public health activities as allowed by state or federal law and in accordance with board rules on data release adopted pursuant to section 8714.   [PL 2013, c. 528, §10 (NEW); PL 2013, c. 528, §12 (AFF).] 3.  Data use agreement.  Prior to disclosing any data under subsection 1, the organization shall enter into a data use agreement with a public health authority. The agreement must include protocols that have been approved by the board for safeguarding confidential information and for ensuring there will be no disclosures of protected health information. The protocols must include appropriate accountability and notification requirements as in the business associate agreements under HIPAA.   [PL 2013, c. 528, §10 (NEW); PL 2013, c. 528, §12 (AFF).] SECTION HISTORY PL 2013, c. 528, §10 (NEW). PL 2013, c. 528, §12 (AFF).
22 ME Rev Stat § 8715-A (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 6: FACILITIES FOR CHILDREN AND ADULTS|Chapter 1683: MAINE HEALTH DATA ORGANIZATION|Subchapter 1: GENERAL PROVISIONS|22 §8715-A. Reporting of cancer data and vital statistics data

 §8715-A. Reporting of cancer data and vital statistics data 1.  Reporting; joint rule-making authority.  The organization and the Department of Health and Human Services may adopt a joint rule to require the reporting to the organization of data from the cancer-incidence registry established pursuant to section 1404 and data related to the registration of vital statistics pursuant to section 2701. The rule adopted pursuant to this section is a routine technical rule as described in Title 5, chapter 375, subchapter 2‑A.   [PL 2021, c. 423, Pt. A, §9 (NEW).] 2.  Confidentiality of data reported.  Data reported to the organization in accordance with subsection 1 is the organization's data and must be protected by privacy and security measures consistent with health care industry standards. The data is confidential and may be released only in accordance with the organization's rule on release of data to the public adopted pursuant to section 8707. Any such cancer data or vital statistics data may be released only in accordance with the organization's rule adopted after the effective date of this subsection.   [PL 2021, c. 423, Pt. A, §9 (NEW).] SECTION HISTORY PL 2021, c. 423, Pt. A, §9 (NEW).
22 ME Rev Stat § 8719 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 6: FACILITIES FOR CHILDREN AND ADULTS|Chapter 1683: MAINE HEALTH DATA ORGANIZATION|Subchapter 1: GENERAL PROVISIONS|22 §8719. Provider database and service locator tool

 §8719. Provider database and service locator tool 1.  Provider database.  The organization shall develop and maintain a multipayor provider database that must be used by the department to provide information for a service locator available on a publicly accessible website for use by the public, by providers and by state agencies in accordance with this section. The organization and the department shall leverage existing data sources to maintain the database whenever possible, as allowable by state and federal law. Creation and maintenance of the database may not increase mandatory reporting requirements for providers of physical health services, and reporting requirements for providers of behavioral health services must be kept to the minimum necessary to ensure development of a useful database and tool for analytic, consumer service and provider identification and referral purposes. The organization shall collaborate with the department as necessary on the development and maintenance of the database.   [PL 2021, c. 423, Pt. B, §3 (NEW).] 2.  Funding.  The development of the multipayor provider database and service locator tool under subsection 1 must be funded using existing resources within the department and grant funding obtained by the department from public and private sources. The organization and the Office of MaineCare Services within the department are jointly responsible for the ongoing maintenance costs of the provider database using existing resources.   [PL 2021, c. 423, Pt. B, §3 (NEW).] SECTION HISTORY PL 2021, c. 423, Pt. B, §3 (NEW).
22 ME Rev Stat § 8731 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 6: FACILITIES FOR CHILDREN AND ADULTS|Chapter 1683: MAINE HEALTH DATA ORGANIZATION|Subchapter 3: PRESCRIPTION DRUG PRICING FOR PURCHASERS|22 §8731. Definitions

 §8731. Definitions As used in this subchapter, unless the context otherwise indicates, the following terms have the following meanings.   [PL 2019, c. 470, §8 (NEW).]1.  Brand-name drug.  "Brand-name drug" means a prescription drug marketed under a proprietary name or registered trademark name, including a biological product.   [PL 2019, c. 470, §8 (NEW).] 1-A.  Drug product family.  "Drug product family" means a group of one or more prescription drugs that share a unique generic drug description and drug form.   [PL 2021, c. 305, §1 (NEW).] 2.  Generic drug.  "Generic drug" means a prescription drug, whether identified by its chemical, proprietary or nonproprietary name, that is not a brand-name drug and is therapeutically equivalent to a brand-name drug in dosage, safety, strength, method of consumption, quality, performance and intended use. "Generic drug" includes a biosimilar product.   [PL 2019, c. 470, §8 (NEW).] 3.  Manufacturer.  "Manufacturer" means an entity that manufactures or repackages, and sets the wholesale acquisition cost for, prescription drugs that are distributed in the State.   [PL 2021, c. 305, §2 (AMD).] 3-A.  Prescription drug.  "Prescription drug" means a drug, as defined in 21 United States Code, Section 321(g) or a biological product as defined in 42 United States Code, Section 262(i)(1) that:   A. Is intended for human use;   [PL 2021, c. 305, §3 (NEW).]B. Is not a device within the meaning of 21 United States Code, Section 321(h); and   [PL 2021, c. 305, §3 (NEW).]C. By federal or state law, can be lawfully dispensed or administered only on prescription by a licensed health care professional.   [PL 2021, c. 305, §3 (NEW).][PL 2021, c. 305, §3 (NEW).] 4.  Pricing component data.  "Pricing component data" means data unique to each manufacturer, wholesale drug distributor or pharmacy benefits manager subject to this subchapter that evidences the cost to each manufacturer, wholesale drug distributor or pharmacy benefits manager to make a prescription drug available to consumers and the payments received by each manufacturer, wholesale drug distributor or pharmacy benefits manager to make a prescription drug available to consumers, taking into account any price concessions, and that is measured uniformly among the entities, as determined by rules adopted by the organization pursuant to section 8737.   [PL 2019, c. 470, §8 (NEW).] 5.  Pricing unit.  "Pricing unit" means the smallest dispensable amount of a prescription drug that could be dispensed.   [PL 2019, c. 470, §8 (NEW).] 6.  Wholesale acquisition cost.  "Wholesale acquisition cost" means a manufacturer's listed price for sale to a wholesale drug distributor or other entity that purchases a prescription drug directly from the manufacturer, not including any price concessions.   [PL 2019, c. 470, §8 (NEW).] SECTION HISTORY PL 2019, c. 470, §8 (NEW). PL 2021, c. 305, §§1-3 (AMD).
22 ME Rev Stat § 8733 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 6: FACILITIES FOR CHILDREN AND ADULTS|Chapter 1683: MAINE HEALTH DATA ORGANIZATION|Subchapter 3: PRESCRIPTION DRUG PRICING FOR PURCHASERS|22 §8733. Confidentiality

 §8733. Confidentiality Information provided to the organization as required by this subchapter by a manufacturer, wholesale drug distributor or pharmacy benefits manager is confidential and not a public record under Title 1, chapter 13, except that the organization may share information:   [PL 2019, c. 470, §8 (NEW).]1.  Bureau of Insurance.  With the Department of Professional and Financial Regulation, Bureau of Insurance, to the extent necessary for the bureau to enforce the provisions of Title 24‑A, as long as any information shared is kept confidential;   [PL 2021, c. 305, §7 (AMD).] 2.  Aggregate.  In the aggregate, as long as it is not released in a manner that allows the determination of individual prescription drug pricing contract terms covering a manufacturer, wholesale drug distributor or pharmacy benefits manager; and   [PL 2021, c. 305, §7 (AMD).] 3.  Publicly available.  That is available, for purchase or otherwise, to the public.   [PL 2021, c. 305, §7 (NEW).] SECTION HISTORY PL 2019, c. 470, §8 (NEW). PL 2021, c. 305, §7 (AMD).
22 ME Rev Stat § 8734 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 6: FACILITIES FOR CHILDREN AND ADULTS|Chapter 1683: MAINE HEALTH DATA ORGANIZATION|Subchapter 3: PRESCRIPTION DRUG PRICING FOR PURCHASERS|22 §8734. Registration requirements

 §8734. Registration requirements Beginning January 1, 2020, manufacturers, wholesale drug distributors and pharmacy benefits managers subject to this subchapter shall register annually with the organization in a manner prescribed by the organization.   [PL 2021, c. 305, §8 (AMD).]SECTION HISTORY PL 2019, c. 470, §8 (NEW). PL 2021, c. 305, §8 (AMD).
22 ME Rev Stat § 8735 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 6: FACILITIES FOR CHILDREN AND ADULTS|Chapter 1683: MAINE HEALTH DATA ORGANIZATION|Subchapter 3: PRESCRIPTION DRUG PRICING FOR PURCHASERS|22 §8735. Compliance

 §8735. Compliance 1.  Certification of accuracy.  A manufacturer, wholesale drug distributor or pharmacy benefits manager that submits a notification or report to the organization pursuant to this subchapter shall submit with the notification or report a signed written certification of the notification's or report's accuracy.   [PL 2019, c. 470, §8 (NEW).] 2.  Civil penalty.  A manufacturer, wholesale drug distributor or pharmacy benefits manager that violates this subchapter commits a civil violation for which a fine of $30,000 may be adjudged for each day of the violation.   [PL 2019, c. 470, §8 (NEW).] 3.  Audit.  The organization may audit the data submitted by a manufacturer, wholesale drug distributor or pharmacy benefits manager pursuant to this subchapter. The manufacturer, wholesale drug distributor or pharmacy benefits manager shall pay for the costs of the audit.   [PL 2019, c. 470, §8 (NEW).] 4.  Corrective action plan.  The organization may require a manufacturer, wholesale drug distributor or pharmacy benefits manager subject to this subchapter to develop a corrective action plan to correct any deficiencies the organization finds with the manufacturer's, wholesale drug distributor's or pharmacy benefits manager's compliance with this subchapter.   [PL 2019, c. 470, §8 (NEW).] SECTION HISTORY PL 2019, c. 470, §8 (NEW).
22 ME Rev Stat § 8736 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 6: FACILITIES FOR CHILDREN AND ADULTS|Chapter 1683: MAINE HEALTH DATA ORGANIZATION|Subchapter 3: PRESCRIPTION DRUG PRICING FOR PURCHASERS|22 §8736. Public report

 §8736. Public report Beginning November 1, 2020 and annually thereafter, the organization shall produce and post on its publicly accessible website an annual report, including information developed from the disclosures received pursuant to this subchapter on trends in the cost of prescription drugs, analysis of manufacturer prices and price increases, the major components of prescription drug pricing along the supply chain and the impacts on insurance premiums and cost sharing and any other information the organization determines is relevant to providing greater consumer awareness of the factors contributing to the cost of prescription drugs in the State. The report may not make public any information that is confidential pursuant to section 8733. The organization shall submit the report required by this section to the joint standing committee of the Legislature having jurisdiction over health data reporting and prescription drug matters and the committee may report out legislation to the first regular or second regular session of the Legislature, depending on the year in which the report is submitted.   [PL 2021, c. 305, §9 (AMD).]SECTION HISTORY PL 2019, c. 470, §8 (NEW). PL 2021, c. 305, §9 (AMD).
22 ME Rev Stat § 8737 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 6: FACILITIES FOR CHILDREN AND ADULTS|Chapter 1683: MAINE HEALTH DATA ORGANIZATION|Subchapter 3: PRESCRIPTION DRUG PRICING FOR PURCHASERS|22 §8737. Rulemaking

 §8737. Rulemaking The organization may adopt rules to implement this subchapter. Rules adopted pursuant to this section are major substantive rules as defined in Title 5, chapter 375, subchapter 2‑A.   [PL 2019, c. 470, §8 (NEW).]SECTION HISTORY PL 2019, c. 470, §8 (NEW).
22-A ME Rev Stat § 101 (2021)
2021 Maine Revised Statutes|TITLE 22-A: HEALTH AND HUMAN SERVICES|Subtitle 1: DEPARTMENT OF HEALTH AND HUMAN SERVICES|Chapter 1: DEPARTMENTAL ORGANIZATION AND OPERATION|Subchapter 1: GENERAL PROVISIONS|22-A §101. Definitions

 §101. Definitions As used in this Title, unless the context otherwise indicates, the following terms have the following meanings.   [PL 2003, c. 689, Pt. A, §1 (NEW).]1.  Commissioner.  "Commissioner" means the Commissioner of Health and Human Services.   [PL 2003, c. 689, Pt. A, §1 (NEW).] 1-A.  Adult developmental services.  "Adult developmental services" has the same meaning as in Title 34‑B, section 1001, subsection 1‑A.   [PL 2011, c. 542, Pt. A, §49 (NEW).] 1-B.  Acquired brain injury.  "Acquired brain injury" has the same meaning as in Title 22, section 3086, subsection 1.   [PL 2021, c. 284, Pt. A, §1 (NEW).] 2.  Department.  "Department" means the Department of Health and Human Services.   [PL 2003, c. 689, Pt. A, §1 (NEW).] 3.  Seal.  The department has an official seal which must be judicially noticed.   [PL 2003, c. 689, Pt. A, §1 (NEW).] SECTION HISTORY PL 2003, c. 689, §A1 (NEW). PL 2011, c. 542, Pt. A, §49 (AMD). PL 2021, c. 284, Pt. A, §1 (AMD).
22-A ME Rev Stat § 201 (2021)
2021 Maine Revised Statutes|TITLE 22-A: HEALTH AND HUMAN SERVICES|Subtitle 1: DEPARTMENT OF HEALTH AND HUMAN SERVICES|Chapter 1: DEPARTMENTAL ORGANIZATION AND OPERATION|Subchapter 2: ORGANIZATION|22-A §201. Department established

 §201. Department established 1.  Establishment.  The Department of Health and Human Services is established as a cabinet-level department.   [PL 2003, c. 689, Pt. A, §1 (NEW).] 2.  Units.   [PL 2007, c. 539, Pt. N, §41 (RP).] 2-A.  Division of departmental responsibilities.  The responsibilities of the department are divided as follows:   A. Financial responsibilities, including but not limited to budget forecasting; audit; Medicaid finance, program and fiscal coordination; purchased services; and ratesetting;   [PL 2007, c. 539, Pt. N, §42 (NEW).]B. Healthcare management and quality responsibilities, including but not limited to licensing and regulatory services, quality improvement, facilities management, Medicaid services oversight, public assistance eligibility and public health and disease control and prevention; and   [PL 2007, c. 539, Pt. N, §42 (NEW).]C. Integrated services responsibilities, including but not limited to:   (1) Adult and elder services, including but not limited to aging, substance use disorder, mental health and disability services;   (2) Child and family services responsibilities, including but not limited to child welfare, children's behavioral health and early childhood services; and   (3) Regional operations.   [PL 2017, c. 407, Pt. A, §89 (AMD).][PL 2017, c. 407, Pt. A, §89 (AMD).] SECTION HISTORY PL 2003, c. 689, §A1 (NEW). PL 2005, c. 412, §5 (AMD). PL 2007, c. 539, Pt. N, §§41, 42 (AMD). PL 2017, c. 407, Pt. A, §89 (AMD).
22-A ME Rev Stat § 202 (2021)
2021 Maine Revised Statutes|TITLE 22-A: HEALTH AND HUMAN SERVICES|Subtitle 1: DEPARTMENT OF HEALTH AND HUMAN SERVICES|Chapter 1: DEPARTMENTAL ORGANIZATION AND OPERATION|Subchapter 2: ORGANIZATION|22-A §202. Mission; guiding principles

 §202. Mission; guiding principles 1.  Mission.  The mission of the department is to provide health and human services to the people of Maine so that all persons may achieve and maintain their optimal level of health and their full potential for economic independence and personal development. Within available funds, the department shall provide supportive, preventive, protective, public health and intervention services to children, families and adults, including the elderly and adults with disabilities. The department shall endeavor to assist individuals in meeting their needs and families in providing for the developmental, health and safety needs of their children, while respecting the rights and preferences of the individual or family.   [PL 2003, c. 689, Pt. A, §1 (NEW).] 2.  Guiding principles.  The following principles are adopted to guide the department. In the performance of its duties, the department shall strive to:   A. Improve the health and well-being of Maine residents, with this goal guiding all decisions, programs and services of the department;   [PL 2003, c. 689, Pt. A, §1 (NEW).]B. Treat consumers with respect and dignity;   [PL 2003, c. 689, Pt. A, §1 (NEW).]C. Treat service providers with professionalism and collegiality;   [PL 2003, c. 689, Pt. A, §1 (NEW).]D. Value and support department staff as the critical connection to the consumer;   [PL 2003, c. 689, Pt. A, §1 (NEW).]E. Involve consumers, providers, advocates and staff in long-term planning;   [PL 2003, c. 689, Pt. A, §1 (NEW).]F. Use relevant, meaningful data and objective analyses of population-based needs in program planning, decision making and quality assurance; and   [PL 2003, c. 689, Pt. A, §1 (NEW).]G. Deliver services that are individualized, family-centered, easily accessible, preventive, independence-oriented, interdisciplinary, collaborative, evidence-based and consistent with best practices.   [PL 2003, c. 689, Pt. A, §1 (NEW).][PL 2003, c. 689, Pt. A, §1 (NEW).] SECTION HISTORY PL 2003, c. 689, §A1 (NEW).
22-A ME Rev Stat § 204 (2021)
2021 Maine Revised Statutes|TITLE 22-A: HEALTH AND HUMAN SERVICES|Subtitle 1: DEPARTMENT OF HEALTH AND HUMAN SERVICES|Chapter 1: DEPARTMENTAL ORGANIZATION AND OPERATION|Subchapter 2: ORGANIZATION|22-A §204. Commissioner

 §204. Commissioner The department is under the control and supervision of the Commissioner of Health and Human Services, who reports directly to the Governor.   [PL 2003, c. 689, Pt. A, §1 (NEW).]1.  Appointment.  The Governor shall appoint the commissioner, subject to review by the joint standing committee of the Legislature having jurisdiction over health and human services matters and confirmation by the Senate. The commissioner serves at the pleasure of the Governor.   [PL 2003, c. 689, Pt. A, §1 (NEW).] 2.  Vacancy; deputy commissioner.  A vacancy in the office of the commissioner must be filled as follows.   A. Any vacancy of the commissioner's position must be filled in accordance with Title 5, section 1.   [PL 2003, c. 689, Pt. A, §1 (NEW).]B. The commissioner shall appoint one of the department's deputy commissioners to perform the duties of the commissioner, in addition to the duties of that deputy commissioner, during the commissioner's temporary absence or disability.   [PL 2003, c. 689, Pt. A, §1 (NEW).][PL 2003, c. 689, Pt. A, §1 (NEW).] SECTION HISTORY PL 2003, c. 689, §A1 (NEW).
22-A ME Rev Stat § 208 (2021)
2021 Maine Revised Statutes|TITLE 22-A: HEALTH AND HUMAN SERVICES|Subtitle 1: DEPARTMENT OF HEALTH AND HUMAN SERVICES|Chapter 1: DEPARTMENTAL ORGANIZATION AND OPERATION|Subchapter 2: ORGANIZATION|22-A §208. Maintenance of state mental health institutes

 §208. Maintenance of state mental health institutes The commissioner shall maintain 2 state mental health institutes for the mentally ill, one at Bangor called the Dorothea Dix Psychiatric Center and the other at Augusta called the Riverview Psychiatric Center.   [PL 2007, c. 539, Pt. N, §47 (NEW).]SECTION HISTORY PL 2007, c. 539, Pt. N, §47 (NEW).
22-A ME Rev Stat § 209 (2021)
2021 Maine Revised Statutes|TITLE 22-A: HEALTH AND HUMAN SERVICES|Subtitle 1: DEPARTMENT OF HEALTH AND HUMAN SERVICES|Chapter 1: DEPARTMENTAL ORGANIZATION AND OPERATION|Subchapter 2: ORGANIZATION|22-A §209. Municipal grants

 §209. Municipal grants The department is authorized to make grants to cities and towns within the State, or to nonprofit corporations organized for purposes related to public health or welfare, out of federal funds when such grants are permitted by the terms under which the federal funds are available. Such grants must be made in conformity with applicable federal requirements and standards and with appropriate state accounting requirements and in accordance with regulations of the department.   [PL 2007, c. 539, Pt. N, §48 (NEW).]SECTION HISTORY PL 2007, c. 539, Pt. N, §48 (NEW).
22-A ME Rev Stat § 210 (2021)
2021 Maine Revised Statutes|TITLE 22-A: HEALTH AND HUMAN SERVICES|Subtitle 1: DEPARTMENT OF HEALTH AND HUMAN SERVICES|Chapter 1: DEPARTMENTAL ORGANIZATION AND OPERATION|Subchapter 2: ORGANIZATION|22-A §210. Fees for service

 §210. Fees for service 1.  Reasonable fees authorized.  The department may charge reasonable fees for any services provided under this Title, Title 5, Title 22 or Title 34-B, whether directly or indirectly provided by the department. Any fees thus received constitute a permanent fund for use by the department as special revenue income and do not become part of the General Fund. Fees so generated must be used in accordance with federal regulations.   [PL 2007, c. 539, Pt. N, §49 (NEW).] 2.  Sliding fee scale.  The department may establish a sliding fee scale for the provision of community-based purchased services administered by the department.   A. The sliding fee scale must be based on gross family income and family size.   [PL 2007, c. 539, Pt. N, §49 (NEW).]B. Any fees charged as a result of implementing this subsection must be paid to the provider of the service and be used by the provider for additional services of the same or related type for which the fees were paid.   [PL 2007, c. 539, Pt. N, §49 (NEW).][PL 2007, c. 539, Pt. N, §49 (NEW).] SECTION HISTORY PL 2007, c. 539, Pt. N, §49 (NEW).
22-A ME Rev Stat § 211 (2021)
2021 Maine Revised Statutes|TITLE 22-A: HEALTH AND HUMAN SERVICES|Subtitle 1: DEPARTMENT OF HEALTH AND HUMAN SERVICES|Chapter 1: DEPARTMENTAL ORGANIZATION AND OPERATION|Subchapter 2: ORGANIZATION|22-A §211. Federal funds and commodities

 §211. Federal funds and commodities The commissioner, with the consent and approval of the Governor, is authorized and empowered to accept any allotments of federal funds and commodities, to manage and dispose of the same in whatever manner required by federal law and put into effect the United States Social Security Act and any amendments of that act and of other federal acts relating to public welfare.   [PL 2007, c. 539, Pt. N, §50 (NEW).]SECTION HISTORY PL 2007, c. 539, Pt. N, §50 (NEW).